ROCK1/ROCK2 inhibitors rescued the efficacy of BBB damage in several CNS diseases, including experimental autoimmune encephalomyelitis, cerebral ischemia, and intracerebral hemorrhage [39]. The gene discussed is ROCK2; the disease is intracerebral hemorrhage.